Home > Journals > Minerva Pediatrics > Past Issues > Minerva Pediatrics 2022 August;74(4) > Minerva Pediatrics 2022 August;74(4):416-20

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

ORIGINAL ARTICLE   

Minerva Pediatrics 2022 August;74(4):416-20

DOI: 10.23736/S2724-5276.18.05057-0

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

Irisin concentration in infant formulas and breast milk

Nina MÓL 1 , Przemysław TOMASIK 2, Katarzyna KLIMASZ 2, Magdalena ZASADA 1, Przemko KWINTA 1

1 Department of Pediatrics, Institute of Pediatrics, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland; 2 Department of Clinical Biochemistry, Institute of Pediatrics, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland



BACKGROUND: Irisin is a newly discovered myokine with antiobesity properties. The delivery of irisin with the breast milk or formula is an emerging concept that myokine present at human milk influences postnatal energy balance and developmental parameters. The aim of the study was to evaluate irisin concentration in breast milk of mothers with term and preterm babies and in infant formulas.
METHODS: A total of 49 lactating mothers were enrolled in the study: 31 mothers of very low birth weight preterm infants and 18 mothers of term infants. Milk samples were collected twice: during the first week after delivery and after 4 weeks of delivery. Irisin concentration was determined using ELISA kits both in human milk and in samples of 14 different infant formulas.
RESULTS: There were no differences in milk irisin levels between preterm and full-term milk samples during both the 1st and the 4th week after delivery. There were also no differences in irisin concentration between transitional milk and mature milk in both tested groups. Irisin concentrations in preterm and full-term milk were significantly higher than in formulas for 30 days period after delivery. A significant increase of irisin concentration in natural milk 4 weeks postdelivery in comparison to 1st week after delivery was observed (mean difference 0.362 µg/mL; P=0.0063).
CONCLUSIONS: This study provides evidence that irisin is present in infant formulas, although in less amount than in human milk. Further research is needed to assess, if children fed with infant formulas may disadvantage from lower irisin supply.


KEY WORDS: Milk, human; Infant formula; Infant, preterm

top of page